2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-07-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP NI689015 2024-07-01 2025-06-30 NI689015 2025-06-30 NI689015 2024-06-30 NI689015 2023-07-01 2024-06-30 NI689015 2024-06-30 NI689015 2023-06-30 NI689015 bus:Director1 2024-07-01 2025-06-30 NI689015 core:WithinOneYear 2025-06-30 NI689015 core:WithinOneYear 2024-06-30 NI689015 core:ShareCapital 2025-06-30 NI689015 core:ShareCapital 2024-06-30 NI689015 core:RetainedEarningsAccumulatedLosses 2025-06-30 NI689015 core:RetainedEarningsAccumulatedLosses 2024-06-30 NI689015 bus:SmallEntities 2024-07-01 2025-06-30 NI689015 bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 NI689015 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 NI689015 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 NI689015 bus:FullAccounts 2024-07-01 2025-06-30
COMPANY REGISTRATION NUMBER: NI689015

Transfer Test Limited

Filleted Unaudited Financial Statements

30 June 2025

Transfer Test Limited

Statement of Financial Position

30 June 2025

| 2025 | 2024
Note | £ | £

Current assets

Debtors | 5 | 34,636 | 22,945
Cash at bank and in hand | 36 | 59
| -------- | --------
| 34,672 | 23,004

Creditors: amounts falling due within one year | 6 | 27,051 | 7,793
| -------- | --------
Net current assets | 7,621 | 15,211
| ------- | --------
Total assets less current liabilities | 7,621 | 15,211
| ------- | --------
Net assets | 7,621 | 15,211
| ------- | --------

Capital and reserves

Called up share capital | 100 | 100
Profit and loss account | 7,521 | 15,111
| ------- | --------
Shareholders funds | 7,621 | 15,211
| ------- | --------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 21 April 2026 , and are signed on behalf of the board by:

Mr C Dillon
Director

Company registration number: NI689015

Transfer Test Limited

Notes to the Financial Statements

Year ended 30 June 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 34a Shore Road, Greenisland, Carrickfergus, Antrim, Northern Ireland, BT38 8UE, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
5. Debtors

| 2025 | 2024
| £ | £
Amounts owed by group undertakings | 34,636 | 22,945
| -------- | --------

6. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Amounts owed to group undertakings | 1,000 | 999
Corporation tax | 3,146 | 6,044
Other creditors | 22,905 | 750
| -------- | -------
| 27,051 | 7,793
| -------- | -------

7. Directors' advances, credits and guarantees
During the year, the company received net loans from the directors of £55 (2024: £Nil). At the year end date, the balance due to the directors was £55 (2024: £Nil).
8. Related party transactions
The company was under the control of Mr C Dillon and Mr S Houston throughout the current period. Mr C Dillon and Mr S Houston are directors and shareholders. The company undertook transactions at arms length with Max Go Limited during the year. Max Go Limited is related by common director and shareholder, Mr C Dillon . At the year end Transfer Test Limited owed Max Go Limited £1,000 (2024: £1,000). The company undertook transactions at arms length with Teaching Cave Limited during the year. Teaching Cave Limited is related by common director and shareholder, Mr C Dillon. At the year end, Teaching Cave Limited owed Transfer Test Limited £34,636 (2024: £22,945). There were no other related party transactions requiring disclosure under FRS102.